<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00053612</url>
  </required_header>
  <id_info>
    <org_study_id>R01AI343844</org_study_id>
    <secondary_id>R01-AI343844</secondary_id>
    <nct_id>NCT00053612</nct_id>
  </id_info>
  <brief_title>Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission</brief_title>
  <official_title>Prevention of HIV Shedding in Women - Trial of Vitamin A</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Allergy and Infectious Diseases (NIAID)</source>
  <brief_summary>
    <textblock>
      HIV infected individuals with vitamin A deficiency may be more likely to transmit the virus&#xD;
      to others than HIV infected individuals who have normal levels of vitamin A. The presence of&#xD;
      HIV DNA in vaginal secretions may indicate a greater risk for transmission of HIV to others.&#xD;
      The purpose of this study is to determine if taking vitamin A decreases the level of HIV DNA&#xD;
      in vaginal secretions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin A deficiency leads to pathological changes in mucosal epithelium, including the&#xD;
      vagina, and is correlated with immune dysfunction in both HIV-1 infected and uninfected&#xD;
      individuals. Recent studies of genital tract shedding of HIV-1 DNA in infected women have&#xD;
      found that lower serum concentrations of vitamin A were strongly associated with detection of&#xD;
      HIV-1 in vaginal secretions. In addition, maternal vitamin A deficiency has been associated&#xD;
      with significantly increased risk of vertical HIV-1 transmission. This study will assess the&#xD;
      effect of vitamin A supplementation on the prevalence and quantity of HIV-1 DNA and RNA in&#xD;
      cervical and vaginal secretions.&#xD;
&#xD;
      Participants in this study will be HIV infected nonpregnant women in Mombasa, Kenya.&#xD;
      Participants will be randomized to receive 6 weeks of daily dosage of either 10,000 IU&#xD;
      vitamin A or placebo. Cervical and vaginal swabs will be obtained at enrollment and at Week 6&#xD;
      for detection and quantification of HIV-1 DNA and RNA. In addition, venous blood will be&#xD;
      obtained at the two time points for quantification of plasma HIV-1 RNA, CD4 lymphocyte count,&#xD;
      and serum vitamin A levels.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <completion_date type="Actual">June 2006</completion_date>
  <primary_completion_date type="Actual">June 2006</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>400</enrollment>
  <condition>HIV Infections</condition>
  <condition>Vitamin A Deficiency</condition>
  <condition>HIV Seronegativity</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin A</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  HIV infected&#xD;
&#xD;
        Exlusion Criteria:&#xD;
&#xD;
          -  Pregnant&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joan Kreiss, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universiy of Washington, Seattle, WA</affiliation>
  </overall_official>
  <verification_date>August 2007</verification_date>
  <study_first_submitted>February 3, 2003</study_first_submitted>
  <study_first_submitted_qc>February 4, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2003</study_first_posted>
  <last_update_submitted>December 13, 2016</last_update_submitted>
  <last_update_submitted_qc>December 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2016</last_update_posted>
  <keyword>HIV-1</keyword>
  <keyword>Women</keyword>
  <keyword>Vitamin A</keyword>
  <keyword>Shedding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Night Blindness</mesh_term>
    <mesh_term>Vitamin A Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin A</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

